SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Kassett Rajni (Last) (First) (Middle) 67 SIMMS DRIVE (Street) AJAX A6 L1T3K1 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 02/18/2015	3. Issuer Name and Ticker or Trading Symbol Kallo Inc. [ KALO ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year) 02/20/2015
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	16,564,547	I	Sister: Anila Makan
Common Stock	5,650,000	I	Friend: Ralph Harmon
Common Stock	1,201,830	I	Friend: Michael Peace
Common Stock	1,513,000	I	Brother: Naresh Kasset
Common Stock	14,215,113	I	2341151 Ontario Incorporated
Common Stock	26,807,834	I	Pearldome Inc.
Common Stock	587,000	I	Jarin Incorporated
Common Stock	200,000	I	Cobramed Pharmaceuticals Limited
Common Stock	50,000	I	FE Pharmacy
Common Stock	200,000	I	Niagara Urgent Care Pharmacy
Common Stock	13,000,000	I	R.P. Kassett Management Co. Ltd
Common Stock	8,000	I	Daughter: Nina Kassett
Common Stock	16,385,191	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Rajni Kassett	08/01/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.